Health Care & Life Sciences » Biotechnology | Aratana Therapeutics Inc.

Aratana Therapeutics Inc. | Ownership

Companies that own Aratana Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Franklin Advisers, Inc.
5,919,277
12.42%
9,311
0.02%
06/30/2018
Broadfin Capital LLC
4,294,426
9.01%
0
3.13%
06/30/2018
Engaged Capital LLC
3,874,411
8.13%
1,474,411
2.83%
08/20/2018
BlackRock Fund Advisors
3,128,162
6.56%
302,806
0%
06/30/2018
The Vanguard Group, Inc.
1,906,105
4%
113,388
0%
06/30/2018
General American Investors Co., Inc. (Investment Management)
1,617,923
3.39%
0
0.66%
06/30/2018
Massachusetts Financial Services Co.
1,376,198
2.89%
365,750
0%
06/30/2018
Dimensional Fund Advisors LP
910,328
1.91%
125,232
0%
06/30/2018
Grandeur Peak Global Advisors LLC
712,138
1.49%
161,675
0.12%
06/30/2018
SSgA Funds Management, Inc.
674,196
1.41%
9,793
0%
06/30/2018

About Aratana Therapeutics

View Profile
Address
11400 Tomahawk Creek Parkway
Leawood Kansas 66211
United States
Employees -
Website http://www.aratana.com
Updated 07/08/2019
Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.